Company Overview - WellTheory, a health technology startup focused on autoimmune care, has secured $14 million in Series A funding led by General Catalyst, with participation from several other investors [1][2] - The company was founded by Ellen Rudolph in 2022, aiming to transform traditional care models for autoimmune diseases through holistic and personalized programs [2] Market Opportunity - The autoimmune disease market is significant, with over 50 million Americans affected by conditions such as rheumatoid arthritis, lupus, and multiple sclerosis, a number that has more than doubled in the last 30 years [3] - The economic burden of autoimmune diseases is projected to reach $180 billion by 2025, with costs expected to double in the next 15 years if new treatments do not emerge [4] Business Model and Services - WellTheory offers personalized care plans for over 100 distinct autoimmune diagnoses, focusing on the root causes of symptoms rather than treating them in isolation [4] - The company utilizes proprietary AI tools, including Care Hub and Care Scribe, to streamline treatment plans and improve operational efficiency [5] Team and Support Structure - Members of WellTheory work with a human care team that includes a registered dietitian, a certified health coach, and a care coordinator, providing one-on-one sessions and unlimited messaging [6] Funding Significance - The recent funding round is notable as all institutional investors involved were female partners, highlighting the rarity of female-led startups receiving venture capital, which accounts for less than 2% of total funding [6]